H. Lijnen

发表

Functional role of ADAMTS5 in adiposity and metabolic health

P. Bedossa, D. Bauters, H. Lijnen, 2018, PloS one.

Loss of ADAMTS5 enhances brown adipose tissue mass and promotes browning of white adipose tissue via CREB signaling

D. Bauters, H. Lijnen, B. Hemmeryckx, 2017, Molecular metabolism.

Impact of Clock Gene Bmal1 Deficiency on Nutritionally Induced Obesity in Mice

U. Himmelreich, M. Hoylaerts, H. Lijnen, 2011, Obesity.

New insights into the molecular mechanisms of the fibrinolytic system

H. Lijnen, H. Lijnen, D. Rijken, 2009, Journal of thrombosis and haemostasis : JTH.

Inactivation of Plasminogen Activator Inhibitor-1 by Specific Proteolysis with Stromelysin-1 (MMP-3)*

P. Declerck, R. Lijnen, H. Lijnen, 2000, The Journal of Biological Chemistry.

Fibrinolytic cross-talk: a new mechanism for plasmin formation.

H. Lijnen, E. Angles-cano, Loïc Doeuvre, 2010, Blood.

Basic and Clinical Aspects of Fibrinolysis and Thrombolysis

H. Lijnen, D. Collen, Desire Collen, 1991 .

Pressure-Induced Matrix Metalloproteinase-9 Contributes to Early Hypertensive Remodeling

A. Tedgui, H. Lijnen, B. Esposito, 2004, Circulation.

Issue Editorial Focus : Issue Editorial Focus

H. Lijnen, D. Collen, 2005 .

Thrombolytic agents

R. Lijnen, H. Lijnen, D. Collen, 2005, Thrombosis and Haemostasis.

Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity.

Carine Munaut, Alain Colige, C. Munaut, 2002, Diabetes.

Novel thrombolytic agents

H. Lijnen, M. Verstraete, 1994, Cardiovascular Drugs and Therapy.

Expression of aggrecan(ases) during murine preadipocyte differentiation and adipose tissue development.

H. Lijnen, J. Sandy, D. Collen, 2006, Biochimica et biophysica acta.

CD36 deficiency blunts effects of diet on regulatory T cells in murine gonadal adipose tissue and mesenteric lymph nodes.

Christine Vranckx, I. Scroyen, H. Lijnen, 2015, Cellular immunology.

Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death

G. Vanhoutte, M. Verhoye, I. Blockx, 2014, European heart journal.

Vascular Endothelial Cell Function and Thrombosis

H. Lijnen, J. Arnout, D. Collen, 2007 .

Generation of a Stable Activated Thrombin Activable Fibrinolysis Inhibitor Variant*

A. Gils, P. Declerck, H. Lijnen, 2006, Journal of Biological Chemistry.

CD9 Gene Deficiency Does not Affect Smooth Muscle Cell Migration and Neointima Formation after Vascular Injury in Mice

H. Lijnen, C. Boucheix, F. Le Naour, 2000, Thrombosis and Haemostasis.

Antioxidant Treatment Improves Cardiac Dysfunction in a Murine Model of Premature Aging

J. Wojta, H. Lijnen, B. Hemmeryckx, 2016, Journal of cardiovascular pharmacology.

Influence of t-PA and u-PA on Adipose Tissue Development in a Murine Model of Diet-Induced Obesity

P. Morange, D. Bastelica, H. Lijnen, 2002, Thrombosis and Haemostasis.

Protease Nexin-1 Inhibits Plasminogen Activation-induced Apoptosis of Adherent Cells*

J. Michel, P. Rossignol, H. Lijnen, 2004, Journal of Biological Chemistry.

Elements of the Fibrinolytic System

H. Lijnen, 2001, Annals of the New York Academy of Sciences.

Modulation of angiogenesis during adipose tissue development in murine models of obesity.

R. Lijnen, H. Lijnen, D. Collen, 2005, Endocrinology.

Role of Gas-6 in Adipogenesis and Nutritionally Induced Adipose Tissue Development in Mice

P. Carmeliet, H. Lijnen, D. Collen, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Effect of fumagillin on adipocyte differentiation and adipogenesis.

V. Christiaens, I. Scroyen, H. Lijnen, 2010, Biochimica et biophysica acta.

ADAMTS5 promotes murine adipogenesis and visceral adipose tissue expansion

I. Scroyen, D. Bauters, H. Lijnen, 2016, Thrombosis and Haemostasis.

Reproducibility of studies with genetically modified mice

H. Lijnen, 2017, Journal of thrombosis and haemostasis : JTH.

Deficiency of plasminogen activator inhibitor‐2 impairs nutritionally induced murine adipose tissue development

I. Scroyen, H. Lijnen, H. Lijnen, 2007, Journal of thrombosis and haemostasis : JTH.

Fumagillin Reduces Adipose Tissue Formation in Murine Models of Nutritionally Induced Obesity

H. Lijnen, B. Hoef, L. Frederix, 2010, Obesity.

The Gustatory Signaling Pathway and Bitter Taste Receptors Affect the Development of Obesity and Adipocyte Metabolism in Mice

J. Buyse, J. Tack, B. Avau, 2015, PloS one.

Murine models of obesity and hormonal therapy.

H. Lijnen, 2011, Thrombosis research.

Role of fibrinolysis in obesity and thrombosis.

H. Lijnen, 2009, Thrombosis research.

Monitoring reperfused myocardial infarction with delayed left ventricular systolic dysfunction in rabbits by longitudinal imaging.

Y. Ni, Jun Wu, R. Oyen, 2018, Quantitative imaging in medicine and surgery.

Coronary thrombolysis in dogs with intravenously administered human pro-urokinase.

H. Lijnen, I. Jang, D. Collen, 1985, Circulation.

Modulation of Fibrinolytic and Gelatinolytic Activity during Adipose Tissue Development in a Mouse Model of Nutritionally Induced Obesity

H. Lijnen, D. Collen, B. van Hoef, 2002, Thrombosis and Haemostasis.

Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice.

H. Lijnen, D. Collen, B. van Hoef, 1998, Blood.

Gelatinase A (MMP-2) promotes murine adipogenesis.

I. Scroyen, D. Bauters, H. Lijnen, 2015, Biochimica et biophysica acta.

No functional role of plasminogen activator inhibitor‐1 in murine adipogenesis or adipocyte differentiation

V. Christiaens, I. Scroyen, H. Lijnen, 2007, Journal of thrombosis and haemostasis : JTH.

Nutritionally Induced Obesity Is Attenuated in Transgenic Mice Overexpressing Plasminogen Activator Inhibitor-1

P. Morange, M. Alessi, H. Lijnen, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Matrix Metalloproteinase Inhibition Impairs Adipose Tissue Development in Mice

H. Lijnen, D. Collen, B. van Hoef, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.

P. Morange, D. Collen, M. Alessi, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue.

P. Morange, H. Lijnen, P. Vague, 1999, Diabetes.

Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants

B. Sobel, D. Schneider, H. Lijnen, 2007, Histochemistry and Cell Biology.

A functional role of gelatinase A in the development of nutritionally induced obesity in mice

H. Lijnen, M. Van Hul, 2008, Journal of thrombosis and haemostasis : JTH.

Adipocyte Hypertrophy in Stromelysin-3 Deficient Mice with Nutritionally Induced Obesity

H. Lijnen, M. Rio, D. Collen, 2002, Thrombosis and Haemostasis.

Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation

H. Lijnen, D. Collen, E. Maquoi, 2003, Thrombosis and Haemostasis.

Effect of Rosiglitazone on Liver Structure and Function in Genetically Diabetic Akita Mice

H. Lijnen, B. Hemmeryckx, Hua-rong Lu, 2013, Basic & clinical pharmacology & toxicology.

FGF receptor antagonism does not affect adipose tissue development in nutritionally induced obesity

Christine Vranckx, I. Scroyen, H. Lijnen, 2014, Adipocyte.

Inhibition of vascular endothelial growth factor receptor tyrosine kinases impairs adipose tissue development in mouse models of obesity.

H. Lijnen, D. Collen, B. van Hoef, 2007, Biochimica et biophysica acta.

Characterization of the murine plasminogen/urokinase-type plasminogen-activator system.

H. Lijnen, D. Collen, B. van Hoef, 1996, European journal of biochemistry.

Tumor Necrosis Factor-α and Angiostatin Are Mediators of Endothelial Cytotoxicity in Bronchoalveolar Lavages of Patients with Acute Respiratory Distress Syndrome

P. Suter, G. Grau, A. Wendel, 2002 .

Caloric restriction improves coagulation and inflammation profile in obese mice.

H. Lijnen, B. Hemmeryckx, M. Van Hul, 2012, Thrombosis research.

Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice?

J. D’hooge, U. Himmelreich, M. Hoylaerts, 2013, European journal of pharmacology.

Temporal and Topographic Matrix Metalloproteinase Expression after Vascular Injury in Mice

P. Carmeliet, D. Goulding, L. Moons, 1999, Thrombosis and Haemostasis.

Overview of Established and New Thrombolytics

H. Lijnen, 2016 .

A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations

S. Kojima, H. Lijnen, S. Smyth, 2007, Journal of thrombosis and haemostasis : JTH.

Thrombolytic Agents in Development

H. Lijnen, M. Verstraete, D. Collen, 1995, Drugs.

Vitronectin Concentrates Proteolytic Activity on the Cell Surface and Extracellular Matrix by Trapping Soluble Urokinase Receptor-Urokinase Complexes

K. Preissner, S. Kanse, H. Lijnen, 1998 .

Prothrombotic effect of Rofecoxib in a murine venous thrombosis model.

M. Hoylaerts, H. Lijnen, N. Nagai, 2008, Thrombosis research.

Gelatinase B (MMP-9) deficiency does not affect murine adipose tissue development

H. Lijnen, M. Van Hul, H. Piccard, 2010, Thrombosis and Haemostasis.

Plasmin and Matrix Metalloproteinases in Vascular Remodeling

H. Lijnen, 2001, Thrombosis and Haemostasis.

The hyperfibrinolytic state of mice with combined thrombin‐activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor‐1 gene deficiency is critically dependent on TAFI deficiency

A. Gils, H. Lijnen, M. Peeters, 2012, Journal of thrombosis and haemostasis : JTH.

Role of the Plasminogen and MMP Systems in Wound Healing

H. Lijnen, D. Collen, H. Lijnen, 2003 .

Effect of vascular endothelial growth factor receptor 2 antagonism on adiposity in obese mice.

I. Scroyen, H. Lijnen, H. Lijnen, 2013, Journal of molecular endocrinology.

10 New thrombolytic agents and strategies

H. Lijnen, D. Collen, 1995 .

Endogenous α2‐antiplasmin does not enhance glomerular fibrin deposition or injury in glomerulonephritis

M. Dewerchin, H. Lijnen, A. Kitching, 2003, Journal of thrombosis and haemostasis : JTH.

Advanced-age C57BL/6JRj mice do not develop obesity upon western-type diet exposure

Ellen Vercalsteren, Christine Vranckx, I. Scroyen, 2019, Adipocyte.

Synthetic Substrates in Clinical Blood Coagulation Assays

H. Lijnen, M. Verstraete, D. Collen, 1980, Developments in Hematology.

Enzyme-linked immunosorbent assay for the specific detection of angiostatin-like plasminogen moieties in biological samples.

H. Lijnen, D. Collen, H. Lijnen, 2001, Thrombosis research.

Dual effect of apolipoprotein(a) on plasmin(ogen)-induced apoptosis through modulation of cell detachment of adherent cells

P. Rossignol, H. Lijnen, E. Angles-cano, 2005, Thrombosis and Haemostasis.

Axl Deficiency Does Not Affect Adipogenesis or Adipose Tissue Development

I. Scroyen, H. Lijnen, L. Frederix, 2012, Obesity.

Blood Vessel Density in De Novo Formed Adipose Tissue Is Decreased Upon Overexpression of TIMP‐1

B. Geest, I. Scroyen, H. Lijnen, 2010, Obesity.

Stromelysin-2 (MMP-10) deficiency does not affect adipose tissue formation in a mouse model of nutritionally induced obesity.

J. Paramo, H. Lijnen, B. van Hoef, 2009, Biochemical and biophysical research communications.

Effect of tissue inhibitor of matrix metalloproteinases-1 on in vitro and in vivo adipocyte differentiation.

I. Scroyen, H. Lijnen, Leentje Cosemans, 2009, Thrombosis research.

Matrix Metalloproteinase System Deficiencies and Matrix Degradation

H. Lijnen, D. Collen, H. Lijnen, 1999, Thrombosis and Haemostasis.

After Vascular Injury in Mice Tissue Inhibitor of Matrix Metalloproteinases-1 Impairs Arterial Neointima Formation

H. Lijnen, P. Soloway, D. Collen, 1999 .

Comparative thrombolytic and immunogenic properties of staphylokinase and streptokinase

P. Declerck, H. Lijnen, D. Collen, 1992 .

Matrix metalloproteinase inhibition impairs murine adipose tissue development independently of leptin.

H. Lijnen, M. Van Hul, 2011, Endocrine journal.

AHA-Circ. Research

J. Vermylen, M. Dewerchin, M. Hoylaerts, 2001 .

Restoration of thrombolytic potential in plasminogen-deficient mice by bolus administration of plasminogen.

P. Carmeliet, L. Moons, D. Collen, 1996, Blood.

Deficiency of vascular endothelial growth factor-D does not affect murine adipose tissue development.

M. Dewerchin, H. Lijnen, B. van Hoef, 2009, Biochemical and biophysical research communications.

Explanations for coagulation activation after air travel

H. Büller, F. Rosendaal, S. Middeldorp, 2010, Journal of thrombosis and haemostasis : JTH.

Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome.

P. Suter, G. Grau, A. Wendel, 2002, American journal of respiratory and critical care medicine.

Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice

R. Lijnen, H. Lijnen, 2005, Thrombosis and Haemostasis.

Evaluation of Matrix Metalloproteinases in Atherosclerosis Using a Novel Noninvasive Imaging Approach

Z. Fayad, J. Aguinaldo, E. Lancelot, 2008, Arteriosclerosis, thrombosis, and vascular biology.

22nd European Congress on Obesity (ECO2015), Prague, Czech Republic, May 6-9, 2015: Abstracts

J. N. Fidalgo, Jimmy D Bell, L. S. Silveira, 2015, Obesity Facts.

Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes.

K. Preissner, S. Kanse, H. Lijnen, 1998, Blood.

The Fibrinolytic System and Obesity

H. Lijnen, I. Juhan-vague, 2002, Thrombosis and Haemostasis.

Age-associated pro-inflammatory adaptations of the mouse thoracic aorta

M. Hoylaerts, H. Lijnen, B. Hemmeryckx, 2013, Thrombosis and Haemostasis.

Effect of ageing on the murine venous circulation

M. Hoylaerts, H. Lijnen, B. Hemmeryckx, 2012, Histochemistry and Cell Biology.

Impairment of adipose tissue development by hypoxia is not mediated by plasminogen activator inhibitor-1

H. Lijnen, F. Semeraro, D. Collen, 2005, Thrombosis and Haemostasis.

Impaired adipose tissue development in mice with inactivation of placental growth factor function.

P. Carmeliet, V. Christiaens, D. Collen, 2006, Diabetes.

Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders.

K. Preissner, C. Kanthou, O. Benzakour, 1997, Arteriosclerosis, thrombosis, and vascular biology.

The regeneration of the methaemocyanin of Limulus polyphemus by hydrogen sulphide and hydrogen cyanide

H. Lijnen, R. Witters, R. Lontie, 1979 .

Tissue-Type Plasminogen Activator

K. Goa, H. Lijnen, D. Collen, 1989, Drugs.

CD36 promotes adipocyte differentiation and adipogenesis.

V. Christiaens, I. Scroyen, H. Lijnen, 2012, Biochimica et biophysica acta.

Angiogenesis and obesity.

H. Lijnen, 2008, Cardiovascular research.

Pleiotropic functions of plasminogen activator inhibitor‐1

H. Lijnen, 2005, Journal of thrombosis and haemostasis : JTH.

Mice Deficient in the Respiratory Chain Gene Cox6a2 Are Protected against High-Fat Diet-Induced Obesity and Insulin Resistance

P. Carmeliet, L. Scorrano, M. Granvik, 2013, PloS one.

Chronic relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor‐1 knockout mice: the effect of fibrinolysis during neuroinflammation

M. Cuzner, H. Lijnen, G. Pryce, 2008, Neuropathology and applied neurobiology.

Biological Effects of Combined Inactivation of Plasminogen Activator and Plasminogen Activator Inhibitor-1 Gene Function in Mice

P. Carmeliet, L. Moons, H. Lijnen, 1995, Thrombosis and Haemostasis.

Regulation of Gelatinase Activity in Mice with Targeted Inactivation of Components of the Plasminogen/Plasmin System

H. Lijnen, D. Collen, G. Lemmens, 1998, Thrombosis and Haemostasis.

From mice to men – mouse models in obesity research: What can we learn?

I. Scroyen, H. Lijnen, B. Hemmeryckx, 2013, Thrombosis and Haemostasis.

Regulation and Control of the Fibrinolytic System

H. Lijnen, D. Collen, 1990 .

Development of novel thrombolytic agents

H. Lijnen, H. Pannekoek, D. Collen, 1994, Journal of internal medicine.

The pathophysiological role of fibrinolysis inhibitors

H. Lijnen, D. Collen, H. Lijnen, 1984, La Ricerca in clinica e in laboratorio.

Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1.

R. Lijnen, H. Lijnen, D. Collen, 2001, Biochimica et biophysica acta.

Molecular basis of thrombolytic therapy

H. Lijnen, D. Collen, 2000, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Gene targeting in hemostasis. Alpha2-antiplasmin.

H. Lijnen, 2001, Frontiers in bioscience : a journal and virtual library.

The plasminogen‐activation system in ovarian tumors

J. Soria, C. Soria, He Lu, 1993, International journal of cancer.

Growth Arrest-Specific Protein 6 Receptor Antagonism Impairs Adipocyte Differentiation and Adipose Tissue Development in Mice

V. Christiaens, H. Lijnen, Llse Scroyen, 2011, Journal of Pharmacology and Experimental Therapeutics.

Coronary thrombolysis with K1K2PU, a chimeric tissue‐type and urokinase‐type plasminogen activator: A feasibility study in six patients with acute myocardial infarction

D. Collen, H. Lijnen, F. V. de Werf, 1993, Coronary artery disease.

Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.

P. Carmeliet, L. Moons, H. Lijnen, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Obesity and vascular risk

H. Lijnen, 2009, Hämostaseologie.

Rofecoxib impairs adipose tissue development in a murine model of nutritionally induced obesity

H. Lijnen, Hua-rong Lu, D. Gallacher, 2008, Thrombosis and Haemostasis.

Role of proteolysis in development of murine adipose tissue

V. Christiaens, I. Scroyen, H. Lijnen, 2008, Thrombosis and Haemostasis.

Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice.

H. Lijnen, P. Soloway, D. Collen, 1999, Circulation research.

Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation.

H. Lijnen, M. Rio, D. Collen, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Plasminogen activator inhibitor‐1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice

H. Lijnen, N. Nagai, H. Lijnen, 2007, Journal of thrombosis and haemostasis : JTH.

Role of ADAMTS13 in diet-induced liver steatosis.

P. Bedossa, I. Scroyen, H. Lijnen, 2017, Molecular medicine reports.

Thrombolytic Profiles of Clot-Targeted Plasminogen Activators

T. Tollenaere, M. Dewerchin, H. Lijnen, 2005 .

Thrombolytic Profiles of Clot‐Targeted Plasminogen Activators Parameters Determining Potency and Initial and Maximal Rates

M. Dewerchin, H. Lijnen, P. Gaffney, 1993, Circulation.

Comparative Thrombolytic Properties of Tissue-Type Plasminogen Activator and of a Plasminogen Activator Inhibitor-1 -Resistant Glycosylation Variant, in a Combined Arterial and Venous Thrombosis Model in the Dog

B. Keyt, H. Gold, T. Roskams, 1994, Thrombosis and Haemostasis.

Coronary thrombolysis indogswithintravenously administered humanpro-urokinase

H. Lijnen, D. Collen, D. Stump, 1985 .

Plasminogen-dependent and -independent Proteolytic Activity of Murine Endothelioma Cells with Targeted Inactivation of Fibrinolytic Genes

E. Wagner, H. Lijnen, D. Collen, 1997, Thrombosis and Haemostasis.

Adiposity and metabolic health in mice deficient in intestinal alkaline phosphatase

Ellen Vercalsteren, Christine Vranckx, I. Scroyen, 2018, Adipocyte.

The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury

P. Carmeliet, T. van der Poll, V. de Waard, 2005, Journal of thrombosis and haemostasis : JTH.

What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?

S. Janssens, H. Lijnen, 2006, Cardiovascular research.

Prolonged High-Fat Diet Feeding of WHHLMI Rabbits does Not Aggravate Metabolic or Cardiac Dysfunction

Y. Ni, Jun Wu, Yuanbo Feng, 2018 .

Chronic plasminogen activator inhibitor‐1 (PAI‐1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lung

M. Poggi, D. Bastelica, M. Alessi, 2007, Journal of thrombosis and haemostasis : JTH.

Plasminogen activator inhibitor-1 impairs plasminogen activationmediated vascular smooth muscle cell apoptosis

P. Rossignol, H. Lijnen, E. Anglés-Cano, 2006, Thrombosis and Haemostasis.

ADAMTS5 deficiency protects against non‐alcoholic steatohepatitis in obesity

P. Bedossa, D. Cassiman, P. Vermeersch, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Progression of the Prothrombotic State in Aging Bmal1-Deficient Mice

A. Kauskot, M. Hoylaerts, H. Lijnen, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Metalloproteinases in Development and Progression of Vascular Disease

H. Lijnen, 2003, Pathophysiology of Haemostasis and Thrombosis.

Stromelysin‐1 (MMP‐3) is critical for intracranial bleeding after t‐PA treatment of stroke in mice

H. Lijnen, N. Nagai, D. Collen, 2007, Journal of thrombosis and haemostasis : JTH.

Antithrombotic effect of clopidogrel in a vena cava thrombosis model in obese mice.

H. Lijnen, S. Helsen, M. Hoylaerts, 2009, Thrombosis Research.

Tiplaxtinin impairs nutritionally induced obesity in mice

M. Alessi, H. Lijnen, D. Collen, 2006, Thrombosis and Haemostasis.

Adipose Tissue Expression of Gelatinases in Mouse Models of Obesity

P. Morange, H. Lijnen, A. Mertens, 2001, Thrombosis and Haemostasis.

Extracellular proteolysis in the development and progression of atherosclerosis.

H. Lijnen, 2001, Biochemical Society transactions.

Interaction of Heparin with Histidine‐rich Glycoprotein

H. Lijnen, D. Collen, 1989, Annals of the New York Academy of Sciences.

The Anti-Adipogenic Potential of COUP-TFII Is Mediated by Downregulation of the Notch Target Gene Hey1

Christine Vranckx, I. Scroyen, D. Bauters, 2015, PloS one.

Molecular and cellular basis of fibrinolysis

H. Lijnen, D. Collen, 1995 .

Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3).

H. Lijnen, D. Collen, A. Bini, 1998, Biochemistry.

Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development

I. Scroyen, H. Lijnen, B. De Geest, 2006, Thrombosis and Haemostasis.

Does butein affect adipogenesis?

Christine Vranckx, I. Scroyen, D. Bauters, 2019, Adipocyte.

Deficiency of α2‐antiplasmin does not affect murine adipose tissue development

H. Lijnen, 2007, Journal of thrombosis and haemostasis : JTH.

ADAMTS13 deficiency in mice does not affect adipose tissue development.

I. Scroyen, H. Lijnen, L. Geys, 2015, Biochimica et biophysica acta.

Stromelysin-1 (MMP-3)-Independent Gelatinase Expression and Activation in Mice

H. Lijnen, D. Collen, B. Hoef, 1998 .

Platelet rescue by macrophage depletion in obese ADAMTS‐13‐deficient mice at risk of thrombotic thrombocytopenic purpura

I. Scroyen, H. Lijnen, L. Geys, 2018, Journal of thrombosis and haemostasis : JTH.

ADAMTS5 deficiency in mice does not affect cardiac function.

H. Lijnen, B. Hemmeryckx, P. Carai, 2019 .

ADAMTS5 deficiency in mice does not affect cardiac function

H. Lijnen, B. Hemmeryckx, P. Carai, 2019, Cell biology international.

Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.

H. Lijnen, M. Verstraete, D. Collen, 1986, Circulation.

Deficiency of thrombospondin‐1 in mice does not affect adipose tissue development

H. Lijnen, H. Lijnen, G. Voros, 2006, Journal of thrombosis and haemostasis : JTH.

ADAMTS5 deficiency in mice does not affect cardiac function.

H. Lijnen, B. Hemmeryckx, P. Carai, 2019 .

Effect of gelatinase inhibition on adipogenesis and adipose tissue development

U. Himmelreich, D. Bauters, H. Lijnen, 2012, Clinical and experimental pharmacology & physiology.

Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury.

H. Lijnen, 2001, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie.

Characterization of the murine plasma fibrinolytic system.

H. Lijnen, D. Collen, H. Lijnen, 1994, European journal of biochemistry.

Impact of Clock Gene Bmal1 Deficiency on Nutritionally Induced Obesity in Mice

U. Himmelreich, M. Hoylaerts, H. Lijnen, 2011, Obesity.

Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice.

M. Dewerchin, M. Hoylaerts, H. Lijnen, 2000, Blood.

Role of proteolysis in development of murine adipose tissue

V. Christiaens, I. Scroyen, H. Lijnen, 2008, Thrombosis and Haemostasis.

Gelatinase B (MMP-9) gene silencing does not affect murine preadipocyte differentiation

D. Bauters, H. Lijnen, M. Van Hul, 2014, Adipocyte.

Effect of gelatinase inhibition on adipogenesis and adipose tissue development

U. Himmelreich, D. Bauters, H. Lijnen, 2012, Clinical and experimental pharmacology & physiology.

Effect of weight loss on gelatinase levels in obese mice

H. Lijnen, M. Van Hul, 2011, Clinical and experimental pharmacology & physiology.

Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from a novel Chryseobacterium Sp.

I. Roelants, H. Lijnen, D. Collen, 2000, Biochemistry.